LIBRA PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LIBRA PHARMA
Largest movements
- Financial fixed assets +€1.9m
up €1.9m (+129%), from €1.5m to €3.4m
- Tangible fixed assets +€78,172
up €78,172 (+1,685%), from €4,639 to €82,811
of which Leasing and similar rights: +€73,026
- Receivables within one year -€36,909
down €36,909 (-25.8%), from €142,994 to €106,085
of which Other amounts receivable: -€71,326
- Debts after one year +€1.6m
up €1.6m (+7,343%), from €22,426 to €1.7m
- Reserves +€142,477
up €142,477 (+13.8%), from €1.0m to €1.2m
- Tax, wage and social debts +€65,886
up €65,886 (+716%), from €9,204 to €75,090
of which Taxes: +€43,723
- Current portion of long-term debt +€59,283
up €59,283 (+67.3%), from €88,114 to €147,397
- Gross operating margin +€106,891
up €106,891 (+150%), from €71,160 to €178,051
- Financial income +€96,290
up €96,290 (+1,174%), from €8,200 to €104,491
- Staff costs +€51,858
new in 2025: €51,858
- Financial charges +€34,270
up €34,270 (+456%), from €7,508 to €41,778
- Taxes +€11,193
up €11,193 (+50.1%), from €22,333 to €33,526
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,642,900 | €3,565,259 | +€1.9m | +117% |
| Fixed assets | 21/28 | €1,474,016 | €3,452,188 | +€2.0m | +134% |
| Tangible fixed assets | 22/27 | €4,639 | €82,811 | +€78,172 | +1,685% |
| Plant, machinery and equipment | 23 | €3,111 | €2,229 | -€882 | -28.4% |
| Furniture and vehicles | 24 | €1,527 | €7,555 | +€6,028 | +395% |
| Leasing and similar rights | 25 | - | €73,026 | +€73,026 | |
| Financial fixed assets | 28 | €1,469,378 | €3,369,378 | +€1.9m | +129% |
| Current assets | 29/58 | €168,884 | €113,071 | -€55,813 | -33.0% |
| Amounts receivable within one year | 40/41 | €142,994 | €106,085 | -€36,909 | -25.8% |
| Trade receivables | 40 | €16,335 | €50,752 | +€34,417 | +211% |
| Other amounts receivable | 41 | €126,659 | €55,333 | -€71,326 | -56.3% |
| Cash at bank and in hand | 54/58 | €24,350 | €4,502 | -€19,847 | -81.5% |
| Deferred charges and accrued income | 490/1 | €1,540 | €2,483 | +€943 | +61.2% |
| Total equity and liabilities | 10/49 | €1,642,900 | €3,565,259 | +€1.9m | +117% |
| Equity | 10/15 | €1,051,065 | €1,187,701 | +€136,635 | +13.0% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €1,032,824 | €1,175,301 | +€142,477 | +13.8% |
| Distributable reserves | 133 | €1,032,824 | €1,175,301 | +€142,477 | +13.8% |
| Profit (loss) carried forward | 14 | €5,842 | €0 | -€5,842 | -100% |
| Amounts payable | 17/49 | €591,834 | €2,377,558 | +€1.8m | +302% |
| Amounts payable after more than one year | 17 | €22,426 | €1,669,156 | +€1.6m | +7,343% |
| Financial debts | 170/4 | €22,426 | €1,669,156 | +€1.6m | +7,343% |
| Amounts payable within one year | 42/48 | €568,998 | €699,747 | +€130,749 | +23.0% |
| Current portion of amounts payable after more than one year | 42 | €88,114 | €147,397 | +€59,283 | +67.3% |
| Financial debts | 43 | - | €2,381 | +€2,381 | |
| Credit institutions | 430/8 | - | €2,381 | +€2,381 | |
| Trade debts | 44 | €1,917 | €9,357 | +€7,440 | +388% |
| Suppliers | 440/4 | €1,917 | €9,357 | +€7,440 | +388% |
| Taxes, remuneration and social security | 45 | €9,204 | €75,090 | +€65,886 | +716% |
| Taxes | 450/3 | €9,204 | €52,927 | +€43,723 | +475% |
| Remuneration and social security | 454/9 | - | €22,163 | +€22,163 | |
| Other amounts payable | 47/48 | €469,762 | €465,521 | -€4,241 | -0.9% |
| Accrued charges and deferred income | 492/3 | €410 | €8,655 | +€8,245 | +2,011% |
| Remuneration, social security and pensions | 62 | - | €51,858 | +€51,858 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,512 | €13,599 | +€10,087 | +287% |
| Other operating charges | 640/8 | €2,545 | €4,773 | +€2,228 | +87.6% |
| Gross operating margin | 9900 | €71,160 | €178,051 | +€106,891 | +150% |
| Operating profit (loss) | 9901 | €65,103 | €107,820 | +€42,717 | +65.6% |
| Financial income | 75/76B | €8,200 | €104,491 | +€96,290 | +1,174% |
| Recurring financial income | 75 | €8,200 | €104,491 | +€96,290 | +1,174% |
| Financial charges | 65/66B | €7,508 | €41,778 | +€34,270 | +456% |
| Recurring financial charges | 65 | €7,508 | €41,778 | +€34,270 | +456% |
| Profit (loss) for the period before taxes | 9903 | €65,795 | €170,533 | +€104,738 | +159% |
| Income taxes | 67/77 | €22,333 | €33,526 | +€11,193 | +50.1% |
| Profit (loss) for the period | 9904 | €43,462 | €137,007 | +€93,545 | +215% |
| Profit (loss) for the period to be appropriated | 9905 | €43,462 | €137,007 | +€93,545 | +215% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.